Johan Thijs Spoor is the CEO and Director at Perspective Therapeutics Inc., a position he has held with dedication and strategic vision. Prior to his role at Perspective Therapeutics, Spoor amassed a wealth of experience in the biopharmaceutical industry, working with several high-profile companies where he honed his skills in corporate leadership and drug development. His career trajectory includes significant roles that have equipped him with a deep understanding of the complexities involved in bringing innovative therapies from the laboratory to the market. At Perspective Therapeutics Inc., Spoor has been instrumental in steering the company towards its mission of developing cutting-edge treatments for cancer and other diseases. Under his leadership, the company has made notable strides in advancing its pipeline of radiopharmaceuticals, focusing on targeted alpha therapies that promise to revolutionize cancer treatment. Spoor's strategic foresight and commitment to scientific excellence have been pivotal in forging key partnerships and securing funding to support the company's research and development efforts. In addition to his professional achievements, Johan Thijs Spoor is recognized for his contributions to the broader biopharmaceutical community. He actively participates in industry conferences and forums, sharing insights and fostering collaborations that drive the sector forward. His role at Perspective Therapeutics not only involves overseeing the day-to-day operations but also shaping the company's long-term vision, ensuring it remains at the forefront of innovation in targeted cancer therapies.